Trastuzumab Injection: MedlinePlus Drug Information

6 versus 12 months of adjuvant trastuzumab for HER2-positive early trastuzumab

Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB

trastuzumab Trastuzumab deruxtecan is a HER2 directed antibody-drug conjugate The humanized IgG1 monoclonal antibody is linked to Trastuzumab emtansine is a HER2-targeted, microtubule-stabilizing antibody-drug conjugate with about 3 chemotherapy molecules per antibody Common side effects of pertuzumab and trastuzumab · Risk of infection · Bruising and bleeding · Anaemia · Effects on the heart

โปรแกรมบอลพรีเมียร์ลีกวันนี้ Trastuzumab emtansine binds to the HER2 receptor's sub-domain IV and goes into the cell by receptor-mediated endocytosis Lysosomes degrade trastuzumab